Pigmented Lesion Treatment Market Report 2026

The pigmented lesion treatment market size has grown strongly in recent years. It will grow from $3.57 billion in 2025 to $3.84 billion in 2026 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to increasing prevalence of pigmentation disorders, rising consumer awareness of aesthetic treatments, expansion of dermatology clinic networks, improved access to cosmetic dermatology services, growth in medical-grade skincare solutions.

The pigmented lesion treatment market size is expected to see strong growth in the next few years. It will grow to $5.07 billion in 2030 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to increasing demand for minimally invasive procedures, rising adoption of AI-assisted skin analysis, expansion of aesthetic medicine clinics, growing focus on customized treatment outcomes, increasing investments in advanced dermatology devices. Major trends in the forecast period include increasing adoption of advanced laser-based treatments, rising demand for non-invasive pigmentation therapies, growing focus on personalized skin treatment protocols, expansion of energy-based dermatology devices, enhanced emphasis on aesthetic outcome optimization.

The rising prevalence of skin disorders is expected to drive growth in the pigmented lesion treatment market in the coming years. Skin disorders encompass a variety of conditions affecting the structure, function, or appearance of the skin, often presenting symptoms such as inflammation, irritation, or abnormal growths. These include acne, eczema, psoriasis, dermatitis, vitiligo, fungal infections, warts, and skin cancer. Increasing environmental pollution is contributing to the rise in skin disorders, as pollutants can damage the skin barrier and trigger inflammatory or allergic reactions. Pigmented lesion treatments target abnormal skin pigmentation, making them effective for conditions like age spots, melasma, and freckles, improving skin appearance through precise technologies and enhancing dermatological care and patient confidence. For example, in 2023, according to Cancer Australia, approximately 8,257 new cases of melanoma were diagnosed, accounting for 2.6% of all cancer-related deaths. Therefore, the rising prevalence of skin disorders is driving the pigmented lesion treatment market.

Key companies in the pigmented lesion treatment market are developing advanced products such as dual-wavelength fractional laser systems to improve treatment precision and effectiveness for various pigmentation issues. Dual-wavelength fractional lasers combine two wavelengths to target both superficial and deep skin layers simultaneously, enabling more effective treatment of pigmented lesions and skin rejuvenation. For instance, in April 2025, Bausch Health Companies Inc., a Canada-based pharmaceutical company, and Solta Medical Corporation, a US-based aesthetics division of Bausch Health, launched Fraxel FTX, a laser resurfacing system featuring 1550 nm erbium-glass and 1927 nm thulium lasers. The system includes a redesigned, 20% lighter handpiece with integrated cooling technology for patient comfort, intelligent optical tracking with Accutrac for precise treatment delivery, and a modern color touchscreen interface for customizable options.

In April 2024, Hahn & Company LLC, a South Korea-based private equity firm, acquired Cynosure LLC for an undisclosed amount. Through this acquisition, Hahn & Company combined Cynosure and Lutronic into Cynosure Lutronic Inc., integrating technological innovations, expanding market reach, enhancing R&D, and offering comprehensive solutions. Cynosure LLC is a US-based medical aesthetics technology company that provides laser systems for pigmented lesion treatment.

Major companies operating in the pigmented lesion treatment market are EL.EN S.p.A., Candela Medical Corporation, Alma Lasers Ltd., Cutera Inc., Lutronic Corporation, Fotona d.o.o., Sciton Inc., Solta Medical Inc., Inmode Ltd., Strata Skin Sciences Inc., Lumenis Ltd., Syneron Medical Ltd., Quanta System S.P.A, Sharplight Technologies Ltd., Beijing Sincoheren Science and Technology Development Co. Ltd., Venus Concept Inc., Lynton Lasers Ltd., Eufoton S.R.L., Asclepion Laser Technologies Gmbh, DEKA M.E.L.A. Srl.

North America was the largest region in the pigmented lesion treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pigmented lesion treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pigmented lesion treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are influencing the pigmented lesion treatment market by increasing costs of imported laser systems, energy-based devices, optical components, and dermatology equipment. Clinics and device manufacturers in North America and Europe are most affected due to reliance on imported high-precision aesthetic technologies, while Asia-Pacific faces higher costs for device exports. These tariffs are increasing treatment costs and capital investment requirements for clinics. However, they are also encouraging local device manufacturing, regional assembly operations, and innovation in cost-effective dermatology treatment solutions.

The pigmented lesion treatment market research report is one of a series of new reports that provides pigmented lesion treatment market statistics, including pigmented lesion treatment industry global market size, regional shares, competitors with a pigmented lesion treatment market share, detailed pigmented lesion treatment market segments, market trends and opportunities, and any further data you may need to thrive in the pigmented lesion treatment industry. This pigmented lesion treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pigmented lesion treatment involves medical or cosmetic procedures designed to reduce or remove areas of skin discoloration caused by excess melanin, which may result from factors such as sun exposure, hormonal changes, or aging. These treatments aim to even out skin tone, enhance appearance, and address pigmentation-related dermatological or aesthetic concerns.

The primary types of pigmented lesion treatments include laser therapy, topical creams, chemical peels, microdermabrasion, and others. Laser therapy uses focused light energy to target and treat specific tissues for therapeutic or cosmetic purposes. The associated products include lasers and energy-based devices, radiofrequency (RF) devices, micro-focused ultrasound systems, and intense pulsed light (IPL) devices. These treatments are suitable for various age groups, including children, adults, and older adults, and are applied to conditions such as melasma, freckles, age spots, and nevus. The end users include dermatology clinics, medical spas, beauty clinics, and other healthcare or aesthetic facilities.

The pigmented lesion treatment market consists of revenues earned by entities by providing services such as cryotherapy services, phototherapy sessions, pigmentation mapping and monitoring, and customized pigmentation treatment plans. The market value includes the value of related goods sold by the service provider or included within the service offering. The pigmented lesion treatment market also includes sales of cryotherapy equipment, dermabrasion tools, skin-lightening serums, and phototherapy units. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.